Quinoa ameliorates polycystic ovary syndrome via regulating gut microbiota through PI3K/AKT/mTOR pathway and autophagy
Compounded semaglutide can be used for weight loss in obese and overweight adults with at least one weight-related health condition such as high blood pressure, heart disease, high cholesterol levels, and type 2 diabetes
Given semaglutide's long half-life, symptoms may persist for several days to weeks, and patients may require ongoing supportive care and monitoring during this period
Fecal microbiota transplantation (FMT) shows great potential in treating refractory colitis, particularly for recurrent or refractory Clostridium difficile infections, where the core mechanism may involve the donor microbiotas reprogramming of host iron metabolism
GLP-1 therapy works independently of lifestyle discipline it addresses appetite regulation at the neurological level, which is why its particularly effective for patients whose environment consistently works against their weight management goals
The popularity of these drugs has led the public to become more comfortable with injectables and has helped drive attention to other gray-market peptides